Archives: Agenda
PANEL DISCUSSION Identifying the right partners to leverage new technologies in pharma
- Identifying key criteria for selecting the right technology partners in the pharma industry
- Exploring successful case studies of partnerships leveraging new technologies
- Understanding the risks and opportunities in collaborating with technology providers to drive innovation in pharma
| Moderator
Piotr Maślak, Senior Director, Head of Emerging Technologies, AstraZeneca |
Case study of data migration: a nightmare or a real need in 2025?
• Partnering for Transformation – SOLTI chose Flex Databases to address the limitations of their previous CTMS and improve operational efficiency.
• Migration Process – The transition managed through structured planning, tailored configuration, and consistent communication between both teams.
• Operational Improvements – Enhanced reporting, adaptable dashboards, and better oversight of monitoring activities supported by a more intuitive system.
• Key Takeaways – SOLTI’s experience highlights how a well-managed migration can strengthen trial management and prepare organizations for future growth
END OF CONFERENCE
Chairperson’s closing remarks
Clinical trial authorisations processes and practices in Europe
- Key steps and requirements for obtaining trial authorisation in the EU
- Comparing regulatory frameworks and timelines across regions
- Managing workload and compliance with limited resources
- When and why to outsource submissions
- Best practices and tips from experience for efficient submissions
FIRESIDE CHAT Overcoming challenges in multi-country trials
• Managing communication across global teams and sites
• Dealing with logistical issues like shipping and storage
• Ensuring consistent data collection and trial processes across countries
Improving clinical trial execution through data insights
• Leveraging data to inform early protocol design and feasibility
• Identifying optimal countries and investigator networks through data-led geographic analysis
• Benchmarking expected timelines, enrollment performance and cost parameters
• Enhancing site selection and feasibility assessment using integrated datasets and e-feasibility tools
• Applying real-time data monitoring to detect risks and inform mid-trial decision-making
Positioning Switzerland as attractive partner for clinical research outside the EU and CTIS regulation
• Unlock the Swiss potential – Switzerland’s strength and challenges in the clinical trial framework
• Transforming clinical trials in Switzerland – what can be learnt from others
• Navigate the future – how Switzerland embarks for a new era fit for the future